Cardiff Oncology Inc. (CRDF)

3.05

-0.09 (-2.87%)

At close: Apr 01, 2025, 3:59 PM

3.06

0.19%

After-hours: Apr 01, 2025, 07:56 PM EDT

Cardiff Oncology Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-45.43M	-41.44M	-38.7M	-28.29M	-19.31M
Depreciation & Amortization	404K	398K	236K	451K	466.01K
Stock-Based Compensation	4.76M	4.51M	4.26M	3.23M	1.76M
Other Working Capital	671K	3.25M	-1.49M	-2.29M	-654.53K
Other Non-Cash Items	-598K	-921K	772K	2.03M	1.1M
Deferred Income Tax	n/a	n/a	n/a	1.32M	315.01K
Change in Working Capital	3.17M	6.57M	-380K	-1.79M	-654.53K
Operating Cash Flow	-37.69M	-30.89M	-33.82M	-23.04M	-16.31M
Capital Expenditures	-80K	-582K	-892K	-205K	-211.88K
Acquisitions	n/a	n/a	-114K	205K	n/a
Purchase of Investments	-23.56M	-70.08M	-91.23M	-174.38M	n/a
Sales Maturities Of Investments	37.37M	106.86M	130.27M	43.14M	n/a
Other Investing Acitivies	n/a	n/a	114K	-205K	n/a
Investing Cash Flow	13.73M	36.2M	38.15M	-131.45M	-211.88K
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	-414K	-24K	-24.24M
Other Financial Acitivies	373K	n/a	75K	1.29M	49.25M
Financial Cash Flow	53.78M	n/a	75K	35.45M	137.31M
Net Cash Flow	29.82M	5.31M	4.4M	-119.04M	120.79M
Free Cash Flow	-37.77M	-31.47M	-34.71M	-23.25M	-16.53M